Medtronic insider plans Rule 144 sale of 1,483 shares

A Medtronic plc shareholder filed a Rule 144 notice to potentially sell 1,483 vested restricted shares on the NYSE.

Available on EDGAR 09/16/2026 - 02:37 PM EDT Accepted by SEC EDGAR 09/16/2026 - 02:37 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Medtronic plc (MDT) is the issuer of common stock that a holder, Harry Kiil, has notified an intention to sell under Rule 144. The notice covers 1,483 shares of common stock that arose from restricted stock vesting as compensation on July 31, 2026, with potential sales on the NYSE.

Key Figures

Shares to be sold under Rule 144: 1,483 shares Aggregate market value of shares: $138,888.59 Restricted stock vesting date: July 31, 2026 +1 more

4 metrics

Shares to be sold under Rule 144 1,483 shares Common stock of Medtronic plc proposed for sale under Rule 144

Aggregate market value of shares $138,888.59 Reported value for the 1,483 Medtronic plc shares covered by the notice

Restricted stock vesting date July 31, 2026 Date the restricted stock vested as compensation from Medtronic plc

Planned sale notice date September 16, 2026 Date associated with the Form 144 signature and planned sale timing

Key Terms

Rule 144, restricted stock vesting, attorney-in-fact, compensation

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

restricted stock vesting financial

"Common | 07/31/2026 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

attorney-in-fact regulatory

"as attorney-in-fact for Harry Kiil"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

compensation financial

"1483 | 07/31/2026 | Compensation"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Medtronic plc (MDT)?

It discloses that Harry Kiil has filed a notice of proposed sale under Rule 144 for 1,483 shares of Medtronic plc common stock, originating from restricted stock that vested as compensation on July 31, 2026, with potential sales on the NYSE.

How many Medtronic (MDT) shares are covered by this Rule 144 notice?

The notice covers 1,483 shares of Medtronic plc common stock. These shares are tied to a restricted stock vesting event dated July 31, 2026, and are the amount the filer has indicated may be sold under Rule 144.

What is the reported market value of the Medtronic (MDT) shares in this Form 144?

The filing lists an aggregate market value of approximately $138,888.59 for the 1,483 shares of Medtronic plc common stock that are subject to the Rule 144 notice, based on the information provided in the securities information section.

What is the source of the Medtronic (MDT) shares being sold under Rule 144?

The Form 144 states that the 1,483 shares of Medtronic plc common stock come from restricted stock vesting on July 31, 2026, described as compensation from the issuer, Medtronic plc.

Which broker is involved in the proposed Medtronic (MDT) share sale?

The filing identifies Fidelity Brokerage Services LLC as the broker associated with the common stock transaction for the 1,483 Medtronic plc shares, with potential sales to occur on the NYSE as indicated.

Who signed the Form 144 related to Medtronic plc (MDT)?

The Form 144 is signed by /s/ Wade Moss, described as a duly authorized representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Harry Kiil, on September 16, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001708062
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Medtronic plc
SEC File Number	001-36820
Address of Issuer	BUILDING TWO PARKMORE BUSINESS PARK WEST GALWAY IRELAND H91 4K49
Phone	01135314381700
Name of Person for Whose Account the Securities are To Be Sold	KIIL HARRY SKIP
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1483	138888.59	1279137890	09/16/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/31/2026	Restricted Stock Vesting	Issuer			1483	07/31/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Harry Kiil
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)